Live-Vu's video for wound care is needed!
Wound Care Devices: Growth Amid Uncertainty
By Anne Staylor, Medtech Insight 1/2009
Executive Summary
Over the last 15 years, a trend toward evidence-based medicine has led to a greater understanding of the science behind wound healing. This knowledge has fueled an explosion of innovation in technology and in the commercialization of a wide range of new products, generating a worldwide market estimated at $4.5 billion annually, with double-digit growth projected over the next three to five years.
Monday, June 1, 2009
Assisted living demand skyrockets
Live-Vu's main cart/kiosk product has a great Market!
Friday, February 27, 2009 Modified: Wednesday, March 4, 2009
While real estate demand in almost every sector is flat, one sector of the market is off the charts.
The demand for assisted living will outpace the supply of available housing in the coming years, and many facilities in Silicon Valley are already near capacity, with rents ranging from $2,000 to $5,000 per month, depending on services.
Merrill Gardens LLC is capitalizing on the momentum and is set to open two new assisted living facilities in Silicon Valley. One is in the Willow Glen neighborhood of San Jose, while another is planned for the city of Campbell.
The Seattle-based operator is working closely with Barry Swenson Builder to construct the 98-unit facility in Willow Glen that is slated to open on May 1. The Campbell project
is a mixed-use community made up of 101 senior rental units for assisted living, 26 rental units not restricted by age and a separate Alzheimer’s facility. It is scheduled to open in 2011.
CEO Bill Pettit said Merrill Gardens chose Silicon Valley because there haven’t been any new facilities built here in the past decade. Between the two new projects, Pettit said the company has made a $90 million commitment in housing to this market. Merrill Gardens already has assisted living communities in Fremont, Vallejo, Sonoma and Rohnert Park, with 54 communities nationwide.
Big market
Assisted living is a $38 billion industry. Today, 1 million Americans reside in assisted living facilities, according to the National Center for Assisted Living.
Paul Williams, director of government relations with the Assisted Living Federation, said occupancy rates in assisted living have decreased somewhat — from the 90s to the high 80s — but not drastically. The average age of a resident now is 85 years old, but that is going to change.
The need for assisted living is only going to increase once baby boomers
reach that age bracket, Williams said.
Pettit adds that companies will be unable to build communities fast enough to meet the growth of the senior population.
The existing facilities in the United States can serve less than 10 percent of the current 38 million Americans over age 65, Pettit said.
“We’re adding almost 10 million seniors every year,” he said, “and with the rapid increase in seniors, the market will become increasingly competitive to find an assisted living facility.”
Pettit said Merrill Gardens is currently at 91 percent occupancy across the country.
“There’s almost no new development going on in 2009 because of the financial markets, and it takes two years before a building is ready for occupancy,” Pettit said. “Seniors who have held off because of economic conditions will be competing with other seniors when the market normalizes.”
Friday, February 27, 2009 Modified: Wednesday, March 4, 2009
While real estate demand in almost every sector is flat, one sector of the market is off the charts.
The demand for assisted living will outpace the supply of available housing in the coming years, and many facilities in Silicon Valley are already near capacity, with rents ranging from $2,000 to $5,000 per month, depending on services.
Merrill Gardens LLC is capitalizing on the momentum and is set to open two new assisted living facilities in Silicon Valley. One is in the Willow Glen neighborhood of San Jose, while another is planned for the city of Campbell.
The Seattle-based operator is working closely with Barry Swenson Builder to construct the 98-unit facility in Willow Glen that is slated to open on May 1. The Campbell project
is a mixed-use community made up of 101 senior rental units for assisted living, 26 rental units not restricted by age and a separate Alzheimer’s facility. It is scheduled to open in 2011.
CEO Bill Pettit said Merrill Gardens chose Silicon Valley because there haven’t been any new facilities built here in the past decade. Between the two new projects, Pettit said the company has made a $90 million commitment in housing to this market. Merrill Gardens already has assisted living communities in Fremont, Vallejo, Sonoma and Rohnert Park, with 54 communities nationwide.
Big market
Assisted living is a $38 billion industry. Today, 1 million Americans reside in assisted living facilities, according to the National Center for Assisted Living.
Paul Williams, director of government relations with the Assisted Living Federation, said occupancy rates in assisted living have decreased somewhat — from the 90s to the high 80s — but not drastically. The average age of a resident now is 85 years old, but that is going to change.
The need for assisted living is only going to increase once baby boomers
reach that age bracket, Williams said.
Pettit adds that companies will be unable to build communities fast enough to meet the growth of the senior population.
The existing facilities in the United States can serve less than 10 percent of the current 38 million Americans over age 65, Pettit said.
“We’re adding almost 10 million seniors every year,” he said, “and with the rapid increase in seniors, the market will become increasingly competitive to find an assisted living facility.”
Pettit said Merrill Gardens is currently at 91 percent occupancy across the country.
“There’s almost no new development going on in 2009 because of the financial markets, and it takes two years before a building is ready for occupancy,” Pettit said. “Seniors who have held off because of economic conditions will be competing with other seniors when the market normalizes.”
There's No Place Like the Home Health Care Market
Live-Vu's Home Care Kit Market!
Article preview reprinted from Start-Up - February, 2009
The market for home health care products, valued at $4.3 billion today, is one of the largest and most stable medtech markets in the US, and like most health care markets, it owes its growth to the burgeoning aging population. In the year 2010, the number of people age 65 and older in the US is expected to total more than 40.2 million, according to "US Markets for Home Health Care Products," a report recently published by the FDC-Windhover division of Elsevier Business Intelligence.
It's this growth that spawned the critical need for less expensive strategies and technologies used to care for patients sick enough to require chronic care, but healthy enough to live at home. The home market also serves younger, disabled patients who don't require hospitalization and those recovering from acute medical conditions who only need temporary or intermittent home-based medical care.
This population will only grow. As the larger elderly segment of the population ages, they'll require care. But rising health care costs have forced patients to recover from disease and injury at home rather than in an acute care or even rehabilitation setting. A dangerous shortage of facilities, nurses and other skilled health care personnel adds to the pressures and ensures strong growth in the home health care market for the foreseeable future.
The respiratory segment is the largest market in home health care, covering asthma, obstructive sleep apnea, chronic bronchitis, pneumonia, emphysema and cystic fibrosis. In the US, the home respiratory market was estimated at $1.5 billion in 2007, and is expected to grow at a compound annual rate of 4% through 2012. As hospitals continue to look for ways to reduce their costs and better manage patients, new home health care respiratory therapy technology will offer clinically safe, long-term therapy alternatives.
Gaining access to the home respiratory market was part of the rationale behind the acquisition of Respironics Inc. by Royal Philips Electronics NV for $4.9 billion at the end of 2007. Obstructive sleep apnea (OSA) in particular, is emerging as a hot growth segment, due to the enormous patient population: there are 12 million people with OSA in the US. As testament to the promise in this field, 2008 saw four acquisitions and two venture financings of sleep apnea companies. (See "Once Sluggish Sleep Apnea Gets Active," START-UP, January 2009
Article preview reprinted from Start-Up - February, 2009
The market for home health care products, valued at $4.3 billion today, is one of the largest and most stable medtech markets in the US, and like most health care markets, it owes its growth to the burgeoning aging population. In the year 2010, the number of people age 65 and older in the US is expected to total more than 40.2 million, according to "US Markets for Home Health Care Products," a report recently published by the FDC-Windhover division of Elsevier Business Intelligence.
It's this growth that spawned the critical need for less expensive strategies and technologies used to care for patients sick enough to require chronic care, but healthy enough to live at home. The home market also serves younger, disabled patients who don't require hospitalization and those recovering from acute medical conditions who only need temporary or intermittent home-based medical care.
This population will only grow. As the larger elderly segment of the population ages, they'll require care. But rising health care costs have forced patients to recover from disease and injury at home rather than in an acute care or even rehabilitation setting. A dangerous shortage of facilities, nurses and other skilled health care personnel adds to the pressures and ensures strong growth in the home health care market for the foreseeable future.
The respiratory segment is the largest market in home health care, covering asthma, obstructive sleep apnea, chronic bronchitis, pneumonia, emphysema and cystic fibrosis. In the US, the home respiratory market was estimated at $1.5 billion in 2007, and is expected to grow at a compound annual rate of 4% through 2012. As hospitals continue to look for ways to reduce their costs and better manage patients, new home health care respiratory therapy technology will offer clinically safe, long-term therapy alternatives.
Gaining access to the home respiratory market was part of the rationale behind the acquisition of Respironics Inc. by Royal Philips Electronics NV for $4.9 billion at the end of 2007. Obstructive sleep apnea (OSA) in particular, is emerging as a hot growth segment, due to the enormous patient population: there are 12 million people with OSA in the US. As testament to the promise in this field, 2008 saw four acquisitions and two venture financings of sleep apnea companies. (See "Once Sluggish Sleep Apnea Gets Active," START-UP, January 2009
Subscribe to:
Posts (Atom)